Prostate cancer Board decisions

The Veteran's appeal for a TDIU claim was granted, effective March 1, 2022. The Appellant is eligible to attorney fees based on past-due benefits awarded in the November 2022 rating decision.

The Veteran's claims for service connection for coronary artery disease, hypertension, prostate cancer, and bladder cancer are being remanded due to the need for additional medical opinions regarding his exposure to jet fuel exhaust and herbicide agents during service.

The Board has found that the Veteran's service connection claim for prostate cancer should be remanded due to a pre-decisional duty to assist error, specifically regarding exposure to toxic chemicals during service. The AOJ will need to conduct further research and provide a VA medical opinion.

The Veteran's prostate cancer is granted as service connected due to presumed exposure to herbicide agents during his service aboard the USS Ranger, which came within 12 nautical miles of the shores of Vietnam.

The Board has remanded the claims for prostate cancer, gout, and internal hemorrhoids due to insufficient information regarding the Veteran's exposure to toxins during service. The claims will be reconsidered with the inclusion of an Individual Exposure Record (ILER).

The Board has granted service connection for prostate cancer and type 2 diabetes, both related to herbicide agent exposure during service. The ED is also connected to the service-connected prostate cancer.

The Veteran's prostate cancer residuals were rated as postoperative injury to the prostate gland, and an effective date of February 3, 2016, but no earlier, is granted for a 60% rating due to urinary incontinence requiring absorbent materials which must be changed more than four times per day.

The Veteran's service connection claim for prostate cancer is granted, and the claim for EPSA (a laboratory finding) is denied.

The Veteran's heart disability is granted as secondary to service-connected obstructive sleep apnea.,Service connection for prostate cancer is denied.

The Board has granted the Veteran's claim for service connection for a persistent depressive disorder, finding that it is secondary to his service-connected prostate and bladder cancer.

The Veteran's service connection claim for degenerative disc disease was granted. The compensable rating claim for bilateral hearing loss was denied. The prostate cancer claim is being remanded.

The Board denied the Veteran's claim for service connection for prostate cancer, status post-operative, as due to contaminated water at Camp Lejeune (CLJW), finding that the evidence was not persuasive in favor of a link between his prostate cancer and exposure to contaminated water.

The Board granted service connection for hypertension and prostate cancer, both presumed to be related to herbicide exposure during the Veteran's service in Korea. The issues of service connection for bilateral hearing loss and tinnitus were remanded.

The Veteran's claim for an effective date of November 24, 2015, for service connection for bilateral lower extremity radiculopathy of the sciatic nerves is granted. The claim for service connection for prostate cancer is denied.

The Board has remanded the case for further development due to a duty to assist error, including obtaining an addendum VA opinion or additional examination regarding the Veteran's prostate cancer and its potential connection to in-service exposure to ionizing radiation.

The Veteran's hearing loss is granted as service-connected. The Veteran's prostate cancer residuals are denied as not related to service.

The Veteran's appeal for service connection for an acquired psychiatric condition, prostate cancer, and left knee disability is denied due to lack of new and relevant evidence. The VA has remanded the cases for additional development.

The Board has dismissed the Veteran's claims for service connection for right and left knee degenerative arthritis, as these conditions are considered manifestations of previously service-connected disabilities. The appeals for type two diabetes mellitus, prostate cancer, urinary incontinence secondary to prostate cancer, and erectile dysfunction secondary to prostate cancer or post-operative residuals of left knee Osgood-Schlatter's disease have been remanded due to the need for additional development regarding possible exposure to herbicide agents.

The Board has denied the Veteran's claim for service connection for coronary artery disease, and has remanded the claims for service connection for prostate cancer and metastatic bone cancer associated with primary prostate cancer.

The Board has remanded the Veteran's claims for service connection due to his exposure to carbon tetrachloride and ionizing radiation during service. Additional development is needed, including obtaining medical opinions on whether these exposures caused or contributed to the Veteran's claimed conditions.